Hazlett, Burt & Watson’s ResMed RMD Stock Holding History

Hazlett, Burt & Watson’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$105K	Hold	540	–	–	0.03%	356
2026 Q1	$121K	Hold	540	–	–	0.04%	315
2025 Q4	$130K	Hold	540	–	–	0.04%	309
2025 Q3	$148K	Hold	540	–	–	0.05%	268
2025 Q2	$139K	Hold	540	–	–	0.06%	240
2025 Q1	$121K	Sell	540 -100	-16%	-$23.3K	0.05%	251
2024 Q4	$146K	Hold	640	–	–	0.06%	237
2024 Q3	$155K	Hold	640	–	–	0.07%	229
2024 Q2	$121K	Hold	640	–	–	0.06%	247
2024 Q1	$127K	Hold	640	–	–	0.08%	218
2023 Q4	$110K	Sell	640 -22	-3%	-$3.38K	0.07%	211
2023 Q3	$98K	Sell	662 -215	-25%	-$38.9K	0.07%	215
2023 Q2	$192K	Buy	877 +2	+0.2%	+$446	0.14%	143
2023 Q1	$192K	Hold	875	–	–	0.16%	129
2022 Q4	$182K	Hold	875	–	–	0.16%	131
2022 Q3	$191K	Hold	875	–	–	0.18%	112
2022 Q2	$183K	Hold	875	–	–	0.17%	127
2022 Q1	$212K	Buy	+875	New	+$212K	0.17%	126

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Hazlett, Burt & Watson's RMD Position: Q2 2026 in Review

Hazlett, Burt & Watson held its ResMed (RMD) position steady in Q2 2026 at 540 shares worth $105K. The position accounts for 0.03% of the portfolio, ranked #356.

Hazlett, Burt & Watson first reported a position in RMD in Q1 2022 and has held it in 18 quarters since. The position peaked at $212K in Q1 2022. 888 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Hazlett, Burt & Watson held 540 shares of ResMed worth $105K as of Q2 2026.
Hazlett, Burt & Watson left its ResMed share count unchanged in Q2 2026.
ResMed made up 0.03% of Hazlett, Burt & Watson's portfolio in Q2 2026, its #356 holding.
Hazlett, Burt & Watson first reported a position in ResMed in Q1 2022 and has held it in 18 quarters since.
Hazlett, Burt & Watson's ResMed position peaked at $212K in Q1 2022.
888 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q2 2026, filed 30 Jul 2026.